Clinical trial results have demonstrated that the Pfizer-BioNTech Covid-19 vaccine is safe to be used in children aged five to 11 years. — AFP
Pfizer and BioNTech said on Sept 20 (2021) that clinical trial results showed their Covid-19 vaccine is safe and produces a robust immune response in children aged five to 11.
The vaccine would be administered at a lower dosage than for people over 12, they said.
Already a subscriber? Log in.
Unlock 30% Savings on Ad-Free Access Now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
